Monday, May 11, 2026
wellness India Expo
Home Tags HER 2

Tag: HER 2

BioPharma

AstraZeneca India launches Trastuzumab deruxtecan for HER-2 positive metastatic breast cancer...

BioVoice Correspondent -
0
Developed in collaboration with Daiichi Sankyo, Trastuzumab deruxtecan is a specifically engineered HER2-directed antibody drug conjugate
© Copyright © 2022-2025 BioVoiceNews.com All rights reserved.